NewslettersMammary Cell News Sanofi Trial Failure Halts Work on Breast Cancer Treatment Amcenestrant By lbeveridge - August 18, 2022 0 Sanofi has stopped further work on amcenestrant, a treatment once seen to have strong commercial potential in breast cancer, after a second trial failure. [Reuters] Press Release